Work

Guidelines for surveillance after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)

Year: 2025

Type: article

Abstract: The development of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has transformed the landscape of treatment for peritoneal surface malignancies. It has become increasingly clear that oncological surveillance strategies must adapt to the unique challenges posed by this therapeutic approach. Innovations in diagnostic tools, such as advanced imaging techniques and biomarker analysis, have begun to play a pivotal role in tailoring follow-up protocols. Additionally, comprehensive guidelines that integrate tumor-specific characteristics and outcomes from high-volume centers are critical to optimizing long-term care and improving patient prognosis. This article reviews current surveillance practices after CRS + HIPEC, including tumor-specific protocols, international guidelines and the role of multidisciplinary teams. It also addresses systemic challenges, the importance of specialized centers and emerging diagnostic tools such as liquid biopsy and AI-assisted imaging.

Source: Nowotwory Journal of Oncology

DOI: 10.5603/njo.107142

Authors: Krzysztof Szewczyk, Marek Bębenek, Tomasz Jastrzębski, Piotr Rutkowski, Andrzej Rutkowski, Marcin Ziętek

Institutions: University of Wrocław, Wroclaw Medical University, Wrocław University of Science and Technology, Gdańsk Medical University, The Maria Sklodowska-Curie National Research Institute of Oncology

Language: English

Topic: Intraperitoneal and Appendiceal Malignancies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4416227887

FWCI:

Cites:

Cited by:

Related to: